SCOPUS 정보 검색 플랫폼

Journal of Biopharmaceutical Statistics

Volumn 19, Issue 4, 2009, Pages 571-579

On assessing bioequivalence using genomic data with model misspecification

(4) Lu, Qingshu a Tse, Siu Keung b Chow, Shein Chung c,d Yang, Jun e

a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA (China)

b CITY UNIVERSITY OF HONG KONG (Hong Kong)

c DUKE UNIVERSITY SCHOOL OF MEDICINE (United States)

d NATIONAL CHENG KUNG UNIVERSITY (Taiwan)

e AMGEN INC (United States)

Author keywords

Average bioequivalence; Biomarker; Model misspecification; Sample size calculation

Indexed keywords

ARTICLE; BIOEQUIVALENCE; CALCULATION; DATA ANALYSIS; GENOMICS; PHARMACOKINETICS; PRIORITY JOURNAL; QUANTITATIVE STUDY; SAMPLE SIZE; STATISTICAL ANALYSIS; STATISTICAL MODEL;

DATA INTERPRETATION, STATISTICAL; HUMANS; LINEAR MODELS; MODELS, STATISTICAL; NONLINEAR DYNAMICS; NUMERICAL ANALYSIS, COMPUTER-ASSISTED; PHARMACOGENETICS; PHARMACOKINETICS; REPRODUCIBILITY OF RESULTS; SAMPLE SIZE; THERAPEUTIC EQUIVALENCY;

EID: 70449638011 PISSN: 10543406 EISSN: 15205711 Source Type: Journal
DOI: 10.1080/10543400902963177 Document Type: Article

Times cited : (4)

References (5)

1
- 0003455049
- New York: Chapman Hall/CRC Press, Taylor & Francis
- Chow, S. C., Liu, J. P. (2000). Design and Analysis of Bioavailability and Bioequivalence Studies. New York: Chapman Hall/CRC Press, Taylor & Francis.
- (2000) Design and Analysis of Bioavailability and Bioequivalence Studies
- Chow, S.C.¹ Liu, J.P.²

2
- 9244263007
- Assessing bioequivalence using genomic data
- Chow, S. C., Shao, J., Li, L. (2004). Assessing bioequivalence using genomic data. J. Biopharm. Stat. 14:869-880.
- (2004) J. Biopharm. Stat. , vol.14 , pp. 869-880
- Chow, S.C.¹ Shao, J.² Li, L.³

3
- 0003455042
- FDA. Rockville, MD: Center for Drug Evaluation and Research, Food and Drug Administration
- FDA (2002). Draft Guidance on Bioavailability and Bioequivalence Studies for Orally Administered Drug Products-General Considerations. Rockville, MD: Center for Drug Evaluation and Research, Food and Drug Administration.
- (2002) Draft Guidance on Bioavailability and Bioequivalence Studies for Orally Administered Drug Products-General Considerations

4
- 0038637117
- Gene expression in the human intestine and correlation with oral valacyclovir pharmacokinetic parameters
- Landowski, C. P., Sun, D., Foster, D. R., Menon, S. S., Barnett, J. L., Welage, L. S., Ramachandran, C., Amidon, G. L. (2003). Gene expression in the human intestine and correlation with oral valacyclovir pharmacokinetic parameters. J. Pharmacol. Exp. Ther. 306:778-786.
- (2003) J. Pharmacol. Exp. Ther. , vol.306 , pp. 778-786
- Landowski, C.P.¹ Sun, D.² Foster, D.R.³ Menon, S.S.⁴ Barnett, J.L.⁵ Welage, L.S.⁶ Ramachandran, C.⁷ Amidon, G.L.⁸

5
- 34447576857
- Biosimilars: Opportunity or cause for concern?
- Roger, S. D., Mikhail, A. (2007). Biosimilars: Opportunity or cause for concern? J. Pharm. Sci. 10:405-410. (Pubitemid 350065566)
- (2007) Journal of Pharmacy and Pharmaceutical Sciences , vol.10 , Issue.3 , pp. 405-410
- Roger, S.D.¹ Mikhail, A.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.